383 related articles for article (PubMed ID: 26563378)
1. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
[TBL] [Abstract][Full Text] [Related]
2. Urinary Potassium Excretion and Progression of CKD.
Kim HW; Park JT; Yoo TH; Lee J; Chung W; Lee KB; Chae DW; Ahn C; Kang SW; Choi KH; Han SH;
Clin J Am Soc Nephrol; 2019 Mar; 14(3):330-340. PubMed ID: 30765533
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
[TBL] [Abstract][Full Text] [Related]
4. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
So WY; Kong AP; Ma RC; Ozaki R; Szeto CC; Chan NN; Ng V; Ho CS; Lam CW; Chow CC; Cockram CS; Chan JC; Tong PC
Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
[TBL] [Abstract][Full Text] [Related]
5. Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.
Araki S; Haneda M; Koya D; Sugaya T; Isshiki K; Kume S; Kashiwagi A; Uzu T; Maegawa H
Diabetes Care; 2013 May; 36(5):1248-53. PubMed ID: 23223350
[TBL] [Abstract][Full Text] [Related]
6. Urinary sodium and potassium excretion and risk of cardiovascular events.
O'Donnell MJ; Yusuf S; Mente A; Gao P; Mann JF; Teo K; McQueen M; Sleight P; Sharma AM; Dans A; Probstfield J; Schmieder RE
JAMA; 2011 Nov; 306(20):2229-38. PubMed ID: 22110105
[TBL] [Abstract][Full Text] [Related]
7. One-year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end-points in high-risk Japanese patients.
Meguro S; Inaishi J; Sato Y; Komuro I; Itoh H
J Diabetes Investig; 2021 Jul; 12(7):1212-1219. PubMed ID: 33277819
[TBL] [Abstract][Full Text] [Related]
8. Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study.
Kishi F; Nagai K; Takamatsu N; Tominaga T; Tamaki M; Shibata E; Murakami T; Kishi S; Abe H; Koezuka Y; Minagawa N; Ichien G; Doi T
PLoS One; 2018; 13(4):e0195523. PubMed ID: 29624611
[TBL] [Abstract][Full Text] [Related]
9. The ratio of urinary sodium and potassium and chronic kidney disease progression: Results from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD).
Koo H; Hwang S; Kim TH; Kang SW; Oh KH; Ahn C; Kim YH
Medicine (Baltimore); 2018 Nov; 97(44):e12820. PubMed ID: 30383635
[TBL] [Abstract][Full Text] [Related]
10. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
[TBL] [Abstract][Full Text] [Related]
11. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
12. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
[TBL] [Abstract][Full Text] [Related]
13. 24-hour urine phosphorus excretion and mortality and cardiovascular events.
Palomino HL; Rifkin DE; Anderson C; Criqui MH; Whooley MA; Ix JH
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1202-10. PubMed ID: 23539231
[TBL] [Abstract][Full Text] [Related]
14. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
Skupien J; Warram JH; Smiles AM; Niewczas MA; Gohda T; Pezzolesi MG; Cantarovich D; Stanton R; Krolewski AS
Kidney Int; 2012 Sep; 82(5):589-97. PubMed ID: 22622493
[TBL] [Abstract][Full Text] [Related]
15. Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair.
Saratzis A; Sarafidis P; Melas N; Saratzis N; Kitas G
J Vasc Surg; 2013 Oct; 58(4):879-85. PubMed ID: 23683383
[TBL] [Abstract][Full Text] [Related]
16. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes.
Kopf S; Oikonomou D; von Eynatten M; Kieser M; Zdunek D; Hess G; Morcos M; Forsblom C; Bierhaus A; Groop PH; Nawroth PP; Humpert PM
Acta Diabetol; 2014; 51(3):479-89. PubMed ID: 24366425
[TBL] [Abstract][Full Text] [Related]
18. Urinary Sodium and Potassium Excretion and CKD Progression.
He J; Mills KT; Appel LJ; Yang W; Chen J; Lee BT; Rosas SE; Porter A; Makos G; Weir MR; Hamm LL; Kusek JW;
J Am Soc Nephrol; 2016 Apr; 27(4):1202-12. PubMed ID: 26382905
[TBL] [Abstract][Full Text] [Related]
19. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
Tofik R; Torffvit O; Rippe B; Bakoush O
Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in patients with chronic kidney disease: a 5-year retrospective cohort study at a University Hospital in Japan.
Yamashita T; Yoshida T; Ogawa T; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2011 Dec; 15(6):831-40. PubMed ID: 21800234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
